As shown in Fig. 7, we identified three genes (AGXT, PTGER3 and SLC12A3) with lower mRNA levels in tumour samples (Fig. 7A–C), and patients with a high expression of these three genes exhibited prolonged survival (Fig. 7E–G). Here, AGXT is linked to neoplasm.